S-EPMC10477633 - Identifying high-risk stage IIIA cutaneous melanoma patients who might benefit from adjuvant therapy: the importance of micrometastatic tumor burden - OmicsDI

Unknown

Dataset Information

Identifying high-risk stage IIIA cutaneous melanoma patients who might benefit from adjuvant therapy: the importance of micrometastatic tumor burden

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC10477633 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature